Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Clinical trial NCT01137682 · COMPLETED
Trial details
- NCT number
- NCT01137682
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-19
- Primary completion
- 2013-01-22
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.